These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 34314049)
1. Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy. Baj A; Novazzi F; Ferrante FD; Genoni A; Cassani G; Prestia M; Colombo A; Capuano R; Zago C; Pasciuta R; Tamborini A; Rossi A; Tettamanzi E; Catanoso G; Focosi D; Maffioli L; Maggi F J Med Virol; 2021 Dec; 93(12):6460-6461. PubMed ID: 34314049 [No Abstract] [Full Text] [Related]
2. The Emergence of Sars-CoV-2 Variant Lambda (C.37) in South America. Romero PE; Dávila-Barclay A; Salvatierra G; González L; Cuicapuza D; Solís L; Marcos-Carbajal P; Huancachoque J; Maturrano L; Tsukayama P Microbiol Spectr; 2021 Oct; 9(2):e0078921. PubMed ID: 34704780 [No Abstract] [Full Text] [Related]
3. Introduction of SARS-CoV-2 C.37 (WHO VOI lambda) in the Sao Paulo State, Southeast Brazil. Kashima S; Slavov SN; Giovanetti M; Rodrigues ES; Patané JSL; Viala VL; Santos EV; Evaristo M; de Lima LPO; Martins AJ; Dos Santos Barros CR; Marqueze EC; Garibaldi PMM; Ferreira NN; Moraes GR; Brassaloti RA; Cassano RLRC; Mariani PDSC; Kitajima JP; Schlesinger D; Bezerra RS; Assato PA; da Costa FAS; Poleti MD; Lesbon JCC; Mattos EC; Banho CA; Sacchetto L; Grotto RMT; Souza-Neto JA; Fonseca V; de Alcantara LCJ; Nogueira ML; Fukumasu H; Coutinho LL; Borges M; Calado RT; Elias MC; Sampaio SC; Covas DT J Med Virol; 2022 Mar; 94(3):1206-1211. PubMed ID: 34647634 [TBL] [Abstract][Full Text] [Related]
4. Phylogenomics reveals multiple introductions and early spread of SARS-CoV-2 into Peru. Juscamayta-López E; Carhuaricra D; Tarazona D; Valdivia F; Rojas N; Maturrano L; Gavilán R J Med Virol; 2021 Oct; 93(10):5961-5968. PubMed ID: 34185310 [TBL] [Abstract][Full Text] [Related]
5. Genomic analysis reveals a rapid spread and predominance of lambda (C.37) SARS-COV-2 lineage in Peru despite circulation of variants of concern. Padilla-Rojas C; Jimenez-Vasquez V; Hurtado V; Mestanza O; Molina IS; Barcena L; Morales Ruiz S; Acedo S; Lizarraga W; Bailon H; Cáceres O; Galarza M; Rojas-Serrano N; Vargas-Herrera N; Lope-Pari P; Huayra J; Solari L J Med Virol; 2021 Dec; 93(12):6845-6849. PubMed ID: 34370324 [TBL] [Abstract][Full Text] [Related]
6. Low Prevalence of Antibodies to SARS-CoV-2 and Undetectable Viral Load in Seropositive Blood Donors from South-Eastern Italy. Di Stefano M; Sarno M; Faleo G; Farhan Mohamed AM; Lipsi MR; De Nittis R; Bruno SR; De Feo L; Granato T; Corso G; Arena F; Centra M; Lo Caputo S; Margaglione M; Santantonio TA; Fiore JR Acta Haematol; 2021; 144(5):580-584. PubMed ID: 33878755 [TBL] [Abstract][Full Text] [Related]
7. Dissemination and evolution of SARS-CoV-2 in the early pandemic phase in South America. Wolf JM; Streck AF; Fonseca A; Ikuta N; Simon D; Lunge VR J Med Virol; 2021 Jul; 93(7):4496-4507. PubMed ID: 33764553 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 AY.4.2 variant circulating in Italy: Genomic preliminary insight. Angeletti S; Giovanetti M; Fogolari M; Cella E; De Florio L; Lintas C; Veralli R; Francesconi M; Caccuri F; De Cesaris M; De Flora C; Ceccarelli G; Spoto S; Caruso A; Pascarella S; Riva E; Ciccozzi M J Med Virol; 2022 Apr; 94(4):1689-1692. PubMed ID: 34766651 [TBL] [Abstract][Full Text] [Related]
9. Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe. Stefanelli P; Faggioni G; Lo Presti A; Fiore S; Marchi A; Benedetti E; Fabiani C; Anselmo A; Ciammaruconi A; Fortunato A; De Santis R; Fillo S; Capobianchi MR; Gismondo MR; Ciervo A; Rezza G; Castrucci MR; Lista F; Euro Surveill; 2020 Apr; 25(13):. PubMed ID: 32265007 [TBL] [Abstract][Full Text] [Related]
10. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Genome Sequencing from Post-Mortem Formalin-Fixed, Paraffin-Embedded Lung Tissues. Van Campenhout C; De Mendonça R; Alexiou B; De Clercq S; Racu ML; Royer-Chardon C; Rusu S; Van Eycken M; Artesi M; Durkin K; Mardulyn P; Bours V; Decaestecker C; Remmelink M; Salmon I; D'Haene N J Mol Diagn; 2021 Sep; 23(9):1065-1077. PubMed ID: 34153515 [TBL] [Abstract][Full Text] [Related]
11. The first Italian outbreak of SARS-CoV-2 B.1.1.7 lineage in Corzano, Lombardy. Messali S; Campisi G; Giovanetti M; Ciccozzi M; Caruso A; Caccuri F J Med Virol; 2022 Jan; 94(1):413-416. PubMed ID: 34515998 [TBL] [Abstract][Full Text] [Related]
12. What are SARS-CoV-2 genomes from the WHO Africa region member states telling us? Lu L; Lycett S; Ashworth J; Mutapi F; Woolhouse M BMJ Glob Health; 2021 Jan; 6(1):. PubMed ID: 33419930 [No Abstract] [Full Text] [Related]
13. Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K In Vitro. Widera M; Wilhelm A; Hoehl S; Pallas C; Kohmer N; Wolf T; Rabenau HF; Corman VM; Drosten C; Vehreschild MJGT; Goetsch U; Gottschalk R; Ciesek S J Infect Dis; 2021 Oct; 224(7):1109-1114. PubMed ID: 34223909 [TBL] [Abstract][Full Text] [Related]
14. [How to understand the histopathology of SARS and coronavirus disease-19 (COVID-19) associated with acute respiratory distress syndrome]. Chen J Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):289-290. PubMed ID: 32157847 [TBL] [Abstract][Full Text] [Related]
15. Severe acute respiratory syndrome coronavirus 2 infection in those on mepolizumab therapy. Azim A; Pini L; Khakwani Z; Kumar S; Howarth P Ann Allergy Asthma Immunol; 2021 Apr; 126(4):438-440. PubMed ID: 33453381 [No Abstract] [Full Text] [Related]
16. Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights. Nagy-Szakal D; Couto-Rodriguez M; Wells HL; Barrows JE; Debieu M; Butcher K; Chen S; Berki A; Hager C; Boorstein RJ; Taylor MK; Jonsson CB; Mason CE; O'Hara NB Microbiol Spectr; 2021 Oct; 9(2):e0019721. PubMed ID: 34468193 [TBL] [Abstract][Full Text] [Related]
17. Genomic characterization and phylogenetic analysis of SARS-COV-2 in Italy. Zehender G; Lai A; Bergna A; Meroni L; Riva A; Balotta C; Tarkowski M; Gabrieli A; Bernacchia D; Rusconi S; Rizzardini G; Antinori S; Galli M J Med Virol; 2020 Sep; 92(9):1637-1640. PubMed ID: 32222993 [TBL] [Abstract][Full Text] [Related]
18. Novel SARS-CoV-2 Variants in Italy: The Role of Veterinary Public Health Institutes. Lorusso A; Calistri P; Savini G; Morelli D; Ambrosij L; Migliorati G; D'Alterio N Viruses; 2021 Mar; 13(4):. PubMed ID: 33806104 [TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response. Borgogna C; De Andrea M; Griffante G; Lai A; Bergna A; Galli M; Zehender G; Castello L; Ravanini P; Cattrini C; Mennitto A; Gennari A; Gariglio M J Med Virol; 2021 Dec; 93(12):6444-6446. PubMed ID: 34260066 [No Abstract] [Full Text] [Related]
20. Genomic variation and epidemiology of SARS-CoV-2 importation and early circulation in Israel. Zuckerman NS; Bucris E; Drori Y; Erster O; Sofer D; Pando R; Mendelson E; Mor O; Mandelboim M PLoS One; 2021; 16(3):e0243265. PubMed ID: 33770098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]